The Alzheimer’s Association and the U.S. POINTER study’s Coordinating Center at Wake Forest University Medical Center are closely monitoring COVID-19 and are acting to ensure the safety of participants and staff, and to protect the scientific integrity of the study to the best of our ability.
Due to the evolving impact of the novel coronavirus (COVID-19), the U.S. POINTER study will be paused March 23 through July 13, 2020.
Study leadership will conduct ongoing evaluation to determine whether this pause needs to be extended. U.S. POINTER participants are encouraged to reach out to the local site’s study team at any time. It is our highest priority to keep the entire U.S. POINTER “family” safe and healthy.
We continue to connect by mail and telephone with individuals who are interested in the study.